Australia · Delayed Price · Currency is AUD Nova Eye Medical Company Description
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease.
The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma.
The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020.
Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
| Country | Australia |
| Founded | 1970 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 301 |
| CEO | Thomas Spurling |
Contact Details
Address: 107 Rundle Street Kent Town, SA 5067 Australia | |
| Phone | 61 8 8362 0193 |
| Website | nova-eye.com |
Stock Details
| Ticker Symbol | EYE |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000094252 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Victor Previn | Founder and Executive Chairman |
| Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. | MD and Executive Director |
| Kimberley Menzies | Chief Financial Officer |
| Mark Flynn | Investor Relations |
| Kate Hunt | Chief Commercial Officer |
| Joe Bankovich | President of Global Sales |
| Joaquin V. Wolff | President of Ellex iTrack |
| Simon Jeremy Newton Gray BEc, C.A. | Company Secretary |
| Jordan Possingham | Financial Controller |
| Don Watton | Vice President of Global Service |